At Sobi, we are bringing brilliant ideas to life. As a global biopharma company we are unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
Please see our Social Media Community Guidelines here: www.sobi.com/en/social-media-policy
© 2025 Swedish Orphan Biovitrum AB (publ) – All rights reserved
Shared 1 week ago
18 views
Shared 3 weeks ago
96 views
Shared 1 month ago
190 views
Shared 1 month ago
13 views
Shared 1 month ago
35 views
Shared 1 month ago
37 views
Shared 1 month ago
234 views
Shared 1 month ago
42 views
Shared 1 month ago
24 views
Shared 1 month ago
16 views
Shared 3 months ago
22K views
Shared 3 months ago
20K views
Shared 3 months ago
23K views
Shared 3 months ago
23K views
Shared 4 months ago
73 views
Shared 6 months ago
195 views
Shared 6 months ago
47 views
Shared 7 months ago
18 views
Shared 8 months ago
27 views
Shared 8 months ago
288 views
Shared 8 months ago
180 views
Shared 10 months ago
66 views
Shared 10 months ago
631 views
Shared 10 months ago
214 views
Shared 1 year ago
117 views
Shared 1 year ago
36 views
Shared 1 year ago
10 views
Shared 1 year ago
150 views
Shared 1 year ago
159 views
Shared 1 year ago
685 views
Shared 1 year ago
663 views
Shared 1 year ago
2.1K views
Shared 1 year ago
713 views
Shared 1 year ago
138 views
Shared 1 year ago
209 views
Shared 1 year ago
59 views
Shared 1 year ago
36 views
Shared 1 year ago
24 views